Home/ Supplements/ Feverfew/ Standardized Feverfew Leaf Extract

Standardized Feverfew Leaf Extract

product on market Capsule Bluebonnet Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Standardized Feverfew Leaf Extract
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 380.0mg (120 products) 8 studies — no high-quality reviews

Other Ingredients

100% Kosher Vegetable Capsules Vegetable Cellulose Vegetable Magnesium Stearate
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Directions: As a dietary supplement, take one vegetarian capsule daily or as directed by a healthcare practitioner.

Formulation Notes

Bluebonnet’s Standardized Feverfew Leaf Extract Capsules provide a standardized extract of parthenolides, the most researched active constituents found in feverfew.

Available in easy-to-swallow vegetable derived capsules for maximum assimilation/absorption and for a truly vegetarian/vegan formula.

Bluebonnet’s KOF-K certification #K-0000700

0.5% Parthenolides

Vegetarian

Free of milk, egg, fish, crustacean shellfish, tree nuts, peanuts, wheat and soybeans. Also free of yeast, gluten, barley, rice, sodium and sugar.

Additional Information

A clean and gentle water-based extraction method is employed to capture and preserve feverfew’s most valuable components.

1342A

New & improved

K Parve Gluten free V Vegetarian

Metadata

Product Details

UPC / SKU7 43715 01342 1
DSLD Entry Date2018-07-25
Product TypeBotanical
FormCapsule
DSLD ID179437
Data Updated2026-04-11
Research

Research Evidence

10
Research Sources
48
Avg Quality
4
Systematic Review
4
Rct
1
Meta Analysis
1
Cochrane Review
B Feverfew for preventing migraine.
Cochrane Review The Cochrane database of systematic reviews PubMed
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2004 PubMed
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2000 PubMed
C Randomised double-blind placebo-controlled trial of feverfew in migraine prevention
Rct Lancet (London, England) 1988 PubMed
C Feverfew for migraine prophylaxis: a systematic review
Systematic Review Journal of dietary supplements 2009 PubMed DOI
C Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study
Meta Analysis Clinical drug investigation 2006 PubMed
C The combined effect of acupuncture and Tanacetum parthenium on quality of life in women with headache: randomised study
Rct Acupuncture in medicine : journal of the British Medical Acupuncture Society 2012 PubMed DOI
C A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial
Rct Headache 2004 PubMed
C Feverfew as a preventive treatment for migraine: a systematic review
Systematic Review Cephalalgia : an international journal of headache 1998 PubMed
D Efficacy of feverfew as prophylactic treatment of migraine
Rct British medical journal (Clinical research ed.) 1985 PubMed
View all evidence for Feverfew →
Compare

Similar Products

View all Feverfew products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.